BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24991926)

  • 1. Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.
    Rodrigues H; Figueira I; Lopes A; Gonçalves R; Mendlowicz MV; Coutinho ES; Ventura P
    PLoS One; 2014; 9(7):e93519. PubMed ID: 24991926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
    Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
    J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of cognitive behavioral therapy with pharmacotherapy.
    Ganasen KA; Ipser JC; Stein DJ
    Psychiatr Clin North Am; 2010 Sep; 33(3):687-99. PubMed ID: 20599140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
    de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
    J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
    Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
    Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.
    Hofmann SG; Pollack MH; Otto MW
    CNS Drug Rev; 2006; 12(3-4):208-17. PubMed ID: 17227287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
    Hofmann SG; Otto MW; Pollack MH; Smits JA
    Curr Psychiatry Rep; 2015 Jan; 17(1):532. PubMed ID: 25413638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.
    Bürkner PC; Bittner N; Holling H; Buhlmann U
    PLoS One; 2017; 12(3):e0173660. PubMed ID: 28282427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
    Scheeringa MS; Weems CF
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
    Otto MW; Kredlow MA; Smits JAJ; Hofmann SG; Tolin DF; de Kleine RA; van Minnen A; Evins AE; Pollack MH
    Biol Psychiatry; 2016 Aug; 80(4):274-283. PubMed ID: 26520240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing exposure-based therapy from a translational research perspective.
    Hofmann SG
    Behav Res Ther; 2007 Sep; 45(9):1987-2001. PubMed ID: 17659253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial.
    Siegmund A; Golfels F; Finck C; Halisch A; Räth D; Plag J; Ströhle A
    J Psychiatr Res; 2011 Aug; 45(8):1042-7. PubMed ID: 21377691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
    Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
    Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.